The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 8, 2012, Pages 929-940

  Goodhand, J R ^a   Kamperidis, N ^a   Joshi, N M ^a   Wahed, M ^a   Koodun, Y ^a   Cantor, E J ^a   Croft, N M ^a   Langmead, F L ^a   Lindsay, J O ^a   Rampton, D S ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANEMIA; ARTICLE; BANGLADESHIS; CAUCASIAN; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ENTERITIS; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT; PHENOTYPE; POPULATION MIGRATION; PRIORITY JOURNAL; SEX DIFFERENCE; ULCERATIVE COLITIS; UNITED KINGDOM; VITAMIN D DEFICIENCY;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; BANGLADESH; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; OUTPATIENTS; PHENOTYPE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 84858800261     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05043.x     Document Type: Article

References (42)

1. Tsironi E, Feakins RM, Probert CS, Rampton DS, Phil D,. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol 2004; 99: 1749-55.
2. Carr I, Mayberry JF,. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991-1994). Am J Gastroenterol 1999; 94: 2918-22.
3. Walker DG, Williams HR, Kane SP, et al,. Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK. Am J Gastroenterol 2011; 106: 1281-9.
4. GLA. Round ethnic group projections-London plan. Available at:. Accessed December 1, 2011.
5. Stange EF, Travis SP, Vermeire S, et al,. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn's Colitis 2008; 2: 1-23.
6. Van Assche G, Dignass A, Panes J, et al,. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohn's Colitis 2011; 4: 7-27.
7. Vernier-Massouille G, Balde M, Salleron J, et al,. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008; 135: 1106-13.
8. Van Limbergen J, Russell RK, Drummond HE, et al,. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008; 135: 1114-22.
9. Goodhand J, Dawson R, Hefferon M, et al,. Inflammatory bowel disease in young people: the case for transitional clinics. Inflamm Bowel Dis 2010; 16: 947-52.
10. ACORN. Available at:. Accessed February 1, 2011.
11. Silverberg MS, Satsangi J, Ahmad T, et al,. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl. A): 5-36.
12. WHO, UNICEF, UNU. Iron Deficiency Anaemia: Assessment, Prevention and Control. Report of a joint WHO/UNICEF/UNU consultation. In: Geneva: World Health Organization; 1998.
13. Gasche C, Berstad A, Befrits R, et al,. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 1545-53.
14. Cartwright GE, Lee GR,. The anaemia of chronic disorders. Br J Haematol 1971; 21: 147-52.
15. Benchimol EI, To T, Griffiths AM, Rabeneck L, Guttmann A,. Outcomes of pediatric inflammatory bowel disease: socioeconomic status disparity in a universal-access healthcare system. J Pediatr 2011; 158: 960-7.
16. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP,. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001; 120: 1093-9.
17. Loly C, Belaiche J, Louis E,. Predictors of severe Crohn's disease. Scand J Gastroenterol 2008; 43: 948-54.
18. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J,. Predictors of Crohn's disease. Gastroenterology 2006; 130: 650-6.
19. Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB,. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010; 59: 1200-6.
20. NRES. Differentiating audit, service evaluation and research 2007. Available at:. Accessed November 1, 2011.
21. Bhat M, Nguyen GC, Pare P, et al,. Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository. Am J Gastroenterol 2009; 104: 2233-40.
22. White JM, O'Connor S, Winter HS, et al,. Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol 2008; 6: 1361-9.
23. Hou JK, El-Serag H, Thirumurthi S,. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol 2009; 104: 2100-9.
24. Lakatos PL,. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 2006; 12: 6102-8.
25. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF,. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992; 33: 687-93.
26. Pugazhendhi S, Amte A, Balamurugan R, Subramanian V, Ramakrishna BS,. Common NOD2 mutations are absent in patients with Crohn's disease in India. Indian J Gastroenterol 2008; 27: 201-3.
27. Juyal G, Amre D, Midha V, Sood A, Seidman E, Thelma BK,. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians. Aliment Pharmacol Ther 2007; 26: 1325-32.
28. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP,. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004; 99: 2393-404.
29. Loftus EV Jr,. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-17.
30. Karlsen S, Millward D, Sandford A,. Investigating ethnic differences in current cigarette smoking over time using the health surveys for England. Eur J Pub Health 2011 [Epub ahead of print].
31. Alam R, Speed S, Beaver K,. A scoping review on the experiences and preferences in accessing diabetes-related healthcare information and services by British Bangladeshis. Health Soc Care Community 2011; 20: 155-71.
32. Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK,. Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci 2009; 54: 1099-107.
33. Cosnes J, Cattan S, Blain A, et al,. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-50.
34. Wahed M, Goodhand JR, West O, et al,. Tobacco dependence and awareness of health risks of smoking in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011; 23: 90-4.
35. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP,. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996; 110: 424-31.
36. Rashid ST, Bharucha S, Jamallulail SI, et al,. Inflammatory bowel disease in the South Asian population of Northwest England. Am J Gastroenterol 2008; 103: 242-3.
37. Kochhar R, Mehta SK, Nagi B, Bhatia V, Goenka MK, Malik AK,. Extraintestinal manifestations of idiopathic ulcerative colitis. Indian J Gastroenterol 1991; 10: 88-9.
38. Sood A, Midha V, Sood N, Bhatia AS, Avasthi G,. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003; 52: 1587-90.
39. Cross RK, Jung C, Wasan S, Joshi G, Sawyer R, Roghmann MC,. Racial differences in disease phenotypes in patients with Crohn's disease. Inflamm Bowel Dis 2006; 12: 192-8.
40. Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR,. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 1233-9.
41. Garcia-Gonzalez A, Richardson M, Garcia Popa-Lisseanu M, et al,. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2008; 27: 883-9.
42. Vandenbroucke JP, von Elm E, Altman DG, et al,. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007; 4: e297.